What is HMPV? Understanding the Surge of Human Metapneumovirus in China’s Healthcare Crisis
.webp)
What is HMPV? Understanding the Surge of Human Metapneumovirus in China’s Healthcare Crisis
.webp)
Five years after the Covid-19 pandemic, China is now facing a surge in cases of Human Metapneumovirus (HMPV), a respiratory virus that is causing significant concern across the country. Media reports and social media posts suggest that the virus is spreading quickly, with some reports claiming that hospitals and crematoriums are overwhelmed due to the rise in cases.
Videos shared online show crowded hospitals, with people talking about multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and even Covid-19, contributing to the increase in respiratory illnesses. The situation has worsened, with a noticeable rise in sudden deaths, particularly among people aged 40 to 80.
Videos shared online show crowded hospitals, with people talking about multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and even Covid-19, contributing to the increase in respiratory illnesses. The situation has worsened, with a noticeable rise in sudden deaths, particularly among people aged 40 to 80.
According to one post on social media, “China is facing a surge in multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19, overwhelming hospitals and crematoriums. Children’s hospitals are especially burdened by rising cases of pneumonia and ‘white lung’.”
In late December, data from the Chinese Centers for Disease Control (CDC) showed that the number of HMPV cases, especially among children aged 14 and under, was steadily increasing. This trend has been highlighted by China’s state broadcaster, CCTV.
Human Metapneumovirus (HMPV) was first discovered in 2001, although studies suggest it has been affecting humans for over 60 years. It belongs to the same family of viruses as Respiratory Syncytial Virus (RSV). HMPV is found worldwide and can cause both upper and lower respiratory infections. While it can affect people of all ages, young children, older adults, and individuals with weakened immune systems are particularly vulnerable.
According to the US Centers for Disease Control and Prevention (CDC), common symptoms of HMPV include cough, fever, nasal congestion, and difficulty breathing.
Dr. Li Tong Zeng, a chief doctor at Beijing You’an Hospital, explained that HMPV spreads through respiratory droplets, direct contact (like shaking hands), or by touching contaminated surfaces. The virus typically has an incubation period of three to five days.
Experts recommend preventive measures like wearing masks, frequent hand washing, and strengthening immunity to reduce the risk of infection.
However, experts have cautioned against the widespread use of antiviral medications to treat HMPV. In an interview with the National Business Daily, a respiratory expert in Shanghai warned that while symptoms of HMPV resemble those of the common cold, no vaccine exists, and antiviral drugs are not typically effective for this virus.
In 2023, HMPV was reported in several countries, including the Netherlands, the UK, Finland, Australia, Canada, the US, and China.
As China continues to battle this surge in respiratory illnesses, authorities are calling for increased awareness and caution to curb the spread of HMPV and other viruses circulating at the same time.
According to the US Centers for Disease Control and Prevention (CDC), common symptoms of HMPV include cough, fever, nasal congestion, and difficulty breathing.
Dr. Li Tong Zeng, a chief doctor at Beijing You’an Hospital, explained that HMPV spreads through respiratory droplets, direct contact (like shaking hands), or by touching contaminated surfaces. The virus typically has an incubation period of three to five days.
Experts recommend preventive measures like wearing masks, frequent hand washing, and strengthening immunity to reduce the risk of infection.
However, experts have cautioned against the widespread use of antiviral medications to treat HMPV. In an interview with the National Business Daily, a respiratory expert in Shanghai warned that while symptoms of HMPV resemble those of the common cold, no vaccine exists, and antiviral drugs are not typically effective for this virus.
In 2023, HMPV was reported in several countries, including the Netherlands, the UK, Finland, Australia, Canada, the US, and China.
As China continues to battle this surge in respiratory illnesses, authorities are calling for increased awareness and caution to curb the spread of HMPV and other viruses circulating at the same time.
Credit for news- DD
Comments
Post a Comment